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ABSTRACT. Theophylline and caffeine are two drugs
frequently administered to infants at risk for sudden
infant death syndrome, because of their stimulatory ef-
fects on the respiratory system. These drugs are known
to increase gastric acid secretion and to decrease lower
esophageal sphincter pressure that, in turn, possibly in-
creases gastroesophageal reflux (GER). Thirty babies
were tested for GER before and during caffeine treat-
ment. Eighteen were studied under the same conditions
while undergoing theophylline treatment. All results of
pH monitoring before treatment were within normal
ranges. Episodes of GER increased significantly (P <
.001) in about 50% of the group treated with caffeine and
in 66% of the group treated with theophylline. These
results were independent of plasma xanthine concentra-
tions (within or below therapeutic ranges) and of the
efficacy of the drug. In addition, an increase was noted
for the number of episodes of GER in 24 hours (from 5.3
to 17.1 in the caffeine group and from 5.3 to 24.3 in the
theophylline group) and for the time pH was <4 (from
0.87% to 6% in the caffeine group and up to 13% in the
theophylline group). Because GER is another known risk
factor for sudden infant death syndrome, the administra-
tion of xanthine derivatives in babies at risk for sudden
infant death syndrome should be carefully considered in
each case. Pediatrics 1986;77:807-810; sudden infant
death syndrome, gastroesophageal reflux, continuous pH
monitoring, caffeine, theophylline, xanthine derivative.
The continuing care of the child who shows signs
of “infant apnea” or a “near miss” sudden infant
death syndrome (SIDS) episode is difficult in many
respects for both parents and physicians. Much of
the difficulty results from the inability to determine
the precise cause of the observed event. Of all
hypotheses proposed to explain SIDS, those relat-
ing to defective control of ventilation provide the
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major focus for current research. Caffeine and the-
ophylline, two xanthine derivatives, are frequently
administered to these infants because of their po-
tent effects as central nervous system stimulants.
These drugs are reported to stimulate gastric acid
secretion as well as to diminish lower esophageal
sphincter pressure. Therefore, they could increase
episodes of gastroesophageal reflux and conse-
quently induce aspiration and respiratory problems.
MATERIALS AND METHODS
Infants studied were at risk for SIDS. Simulta-
neous cardiorespiratory monitoring for detection of
risk for SIDS and continuous esophageal pH mon-
itoring were performed at the age of 6 to 8 weeks
in a routine screening program. All infants were
born at term from mothers who had uneventful
pregnancies and uncomplicated deliveries. In a
group of 48 infants at risk for SIDS, xanthine
derivatives were administered. “Risk for SIDS” was
defined either as respiratory ataxia with central
apnea episodes lasting longer than 10 seconds, ac-
companied in some cases by cardiac ataxia and a
decrease of the transcutaneous Po2, or as a periodic
respiration of more than 7% of the tracing. For all
investigations the infants were admitted to our
“sleep-unit.” At home, all infants were observed by
respiratory monitoring.
A continuous 24-hour esophageal pH monitoring,
using a Memolog 600 system (Novo Diagnostics),
was performed in all infants before caffeine or
theophylline administration. Monitoring of esoph-
ageal pH is one of the investigations in the routine
screening program for infants at risk for SIDS. The
system collects the registered data and when the
memory is fully loaded it switches off automatically.
During 24 hours, memory storage of 1 pH value per
7.5 seconds is carried out. The readout of data
stored in the Memolog was performed with an
Apple II computer with a central memory capacity
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Figure. Normal pH tracing. Each point represents pH at 7.5-second time interval.
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of 128K bits. The pH electrode was a flexible glass
electrode (type MI 506; Microelectrodes, Inc.) with
a maximal outer body diameter of 1.6 mm. Maximal
pH error in vivo was 0.5 pH unit; the response time
of the electrode was about 5 seconds. Location in
the middle third of the esophagus was determined
with the aid of radioscopy.
The position of the babies was taken into
account’; all infants were studied in the prone p0-
sition.
Caffeine (caffeine citrate) treatment was started
at regular doses (5 mg/kg/d) in 30 infants.2 The
drug was administered as oral drops, two doses
daily.
Theophylline was administered to 18 infants, also
at usual doses (6 mg/kg/d).3 The drug was admin-
istered three times a day, as oral drops. The plasma
xanthine level was monitored at least once a week.
A second cardiorespiratory monitoring and tracing
and continuous pH monitoring were performed
after 3 to 4 weeks of treatment. A third pH moni-
toring was performed 3 to 4 weeks after the treat-
ment was stopped.
The following parameters for gastroesophageal
reflux were studied: periods with a pH <4; the
duration of the longest reflux episode; the total
number of reflux episodes; and the number of reflux
episodes longer than five minutes. In addition to
these parameters, the program (developed by our
unit) provides a pH tracing (Figure). These values
were compared with the results of a control group
(60 healthy newborns).’ For all these parameters
the mean value and standard deviation were cal-
culated. With the aid of a t test we checked whether
the results were different in a statistically signifi-
cant way.
RESULTS
For both the caffeine and the theophylline
groups, all results of pH monitoring before treat-
.. -
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ment were within normal ranges (Table 1), estab-
lished previously by our team.1
Group 1: Caffeine
Thirty babies were treated with caffeine. Before
caffeine administration, pH <4 represented 0.91 ±
0.54% (mean value ± SD) of the total investigated
time. The longest episode of reflux lasted 3.15 ±
1.83 minutes. In 24 hours, 7.52 ± 2.21 episodes of
reflux were observed, and the number of episodes
lasting longer than five minutes was 0.81 ± 0.51.
No statistically significant difference from the con-
trol group was found. Results are shown in Table
2.
Caffeine was administered daily, and plasma 1ev-
els were monitored at least once a week. In about
20% ofthe infants the levels were below therapeutic
ranges, and in 80% of the infants levels were within
therapeutic ranges (5 to 15 tg/mL). A toxic level
was never detected.
The second cardiorespiratory monitoring and
tracing, taken 3 to 4 weeks later, failed to show any
improvement in 90% of the infants. In 10% risk for
SIDS had decreased.
Results of the second pH monitoring, performed
under similar conditions to the first, were within
normal ranges in 50% of the infants studied (sub-
group A, Table 2). In the other 50%, however (sub-
group B), values for all parameters studied were
statistically significantly higher. Duration of pH >4
TABLE 1. Normal Ranges for Results of pH
Monitoring (N = 60)*
Parameter Prone
Position
Supine
Position
Duration pH <4 (%)
Longest episode (mm)
No. of episodes (in 24 h)
No. of episodes >5 mm
0.87 ± 0.75
2.85 ± 2.23
7.45 ± 2.81
0.84 ± 0.70
5.47 ± 1.71
13.30 ± 10.31
25.59 ± 12.94
3.09 ± 0.98
* Values are means ± SD.
ii: tiE
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TABLE 2. Results of pH Monitoring (Prone Position) in Groups Receiving Caffeine and Theophylline*
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Group and Parameter Before
Treatment
Treat ment (3-4 wk) After
Treatment
Subgroup A Subgroup B
Group 1: Caffeine (n = 30)
Duration pH <4 (%) 0.91 ± 0.54 NS 0.98 ± 0.82 S 6.84 ± 2.03 0.98 ± 0.71
Longest episode (mm) 3.15 ± 1.83 NS 4.03 ± 2.03 S 25.20 ± 8.17 2.61 ± 2.46
No. of episodes (in 24 h) 7.52 ± 2.21 NS 8.01 ± 2.54 5 17.10 ± 5.20 7.45 ± 2.93
No. of episodes >5 mm (in 24 h) 0.85 ± 0.51 NS 0.93 ± 0.56 S 5.61 ± 1.24 0.94 ± 0.86
Group 2: Theophylline (n = 18)
Duration pH <4 (%) 0.75 ± 0.58 NS 0.81 ± 0.63 S 13.00 ± 3.21 0.80 ± 0.76
Longest episode (mm) 2.88 ± 2.35 NS 3.05 ± 2.78 5 28.38 ± 10.25 4.15 ± 2.66
No. ofepisodes (in 24 h) 5.80 ± 3.14 NS 7.07 ± 3.26 S 24.33 ± 6.31 6.58 ± 5.15
No. of episodes >5 mm (in 24 h) 0.90 ± 0.76 NS 1.08 ± 0.98 S 7.69 ± 1.24 0.96 ± 0.84
* Values are means ± SD. NS, not significant; S, significant (P < .001). For caffeine treatment, subgroup A: n = 15;
subgroup B: n = 15. For theophylline treatment, subgroup A: n = 6; subgroup B: n = 12.
increased to 6.8 ± 2.03% of the total investigation
time (or 70.1 minutes in 24 hours). The longest
reflux episode increased to 25.20 ± 8.17 minutes.
The number of episodes of reflux reached 17.10 ±
5.20 in 24 hours, or nearly one episode per hour.
The number of episodes of reflux lasting longer
than five minutes increased in a comparable way:
5.61 ± 1.24 in 24 hours. Neither a correlation be-
tween these results and the efficacy of the drug, nor
a correlation between these results and the xan-
thine plasma level could be detected.
Results of pH monitoring performed 3 to 4 weeks
after treatment was stopped, were always within
normal ranges (pH <4: 0.89 ± 0.71%; longest epi-
sode: 2.61 ± 2.46 minutes; number of episodes: 7.45
± 2.93; and number of episodes of lasting longer
than five minutes: 0.94 ± 0.89).
Group 2: Theophylline
Eighteen babies were treated with theophylline.
All investigations before treatment were within
normal ranges (pH <4: 0.75 ± 058%; longest epi-
sode: 2.88 ± 2.35 minutes; number of episodes: 5.80
± 3.14; and number of episodes lasting longer than
five minutes: 0.90 ± 0.76).
Theophylline was administered daily. Plasma
levels were below therapeutic ranges in ±10% of all
infants and within therapeutic ranges in 90% of
infants. No toxic levels were detected.
The second cardiorespiratory monitoring and
tracing showed a diminished risk for SIDS in only
5% of infants. In 95% of the infants, tracings were
similar to the first ones.
Results of the second pH monitoring were within
normal ranges in six infants (33%) (subgroup A,
Table 2). In the other 12 infants, values for all
parameters were significantly higher (subgroup B).
Mean duration of pH >4 increased to 13.0 ± 3.21%
of the total investigation time. The longest episode
of reflux increased to 28.38 ± 10.25 minutes. The
number of episodes of reflux increased to 24.33 ±
6.31 in 24 hours, of which 7.69 ± L24 lasted longer
than five minutes. A correlation between the effi-
cacy of the drug and the plasma levels or pH mon-
itoring could not be observed.
Results of pH monitoring 3 to 4 weeks after
theophylline administration was stopped were nor-
mal for all infants (Table 2).
DISCUSSION
The incidence of SIDS in the general population
is about two per 1000 live births, with notable
regional and ethnic variations.3 The etiology of this
syndrome remains unknown, although a lot of re-
search on its origin has been done in recent years.
Most of the observed factors in SIDS could be
explained on the basis of a mild primary defect of
autonomic control of respiration.4 Some authors5
reported that 7% of children at risk for SIDS have
gastrointestinal reflux associated with apnea. Our
subjects did not belong to this group, as symptoms
of gastrointestinal reflux were absent, and results
of continuous pH monitoring were initially within
normal ranges.
The efficacy of theophylline (average dose 6 mgI
kg/d), administered to full-term infants, aged 0 to
6 weeks, has been reported in infants with a history
of unexplained apnea and respiratory abnormalities
on pneumogram recording.6 The interconversion of
theophylline and caffeine in newborn infants is
100%.2 Caffeine, as well as theophylline, has been
administered frequently to preterm and term in-
fants with respiratory problems.2’57
The adverse effects of caffeine and theophylline
are many. They produce excitation of the central
nervous system at all levels. Increased transmission
of impulses across nerves and synapses and stimu-
lation of the motor end-plate have been demonstra-
ted.7 Episthotonus, fine tremors, and clonic and
tonic movements with exaggeration of reflexes have
been described. Caffeine is a direct cardiac muscle
stimulant, and it causes an increase of inotropy and
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chronotropy.7 Effects on the vascular system in-
dude pulmonary and systemic vascular dilatation
and cerebral constriction. Smooth muscles are re-
laxed by the drug, whereas skeletal muscles are
stimulated. There is increased renal blood flow and
accentuated diuresis. Multiple effects on the endo-
crine system are recognized. A mild increase in
clotting time and a shortened coagulation time are
known. Basal metabolic rate is increased.7
Effects on the gastrointestinal tract are many.
Gastric acid secretion is stimulated, and, therefore,
fluid secretion is increased. Occasional transient
abdominal distention is a well-documented obser-
vation. A decrease in lower esophageal sphincter
pressure has been reported.8’9 This can have adverse
implications for the young infant, eg, episodes of
reflux and aspiration.7 The influence of caffeine on
lower esophageal sphincter pressure seems variable
and a decrease has been reported8 as well as contra-
dicted.7 More recent experience with manometric
studies demonstrated the difficulties of reproducing
consistent results, especially in small infants. This
technique only measures lower esophageal sphinc-
ter pressure and does not indicate whether reflux is
really present.’#{176}
The use of continuous esophageal pH monitoring,
which was popularized by Tuttle in adults, has been
extended to the newborn, infant, and child.’ The
accuracy of extended pH monitoring has been
shown to be as high as 9o%10 We recently published
normal data in asymptomatic newborns showing
that gastrointestinal reflux is physiologic between
certain ranges.’
The administration of caffeine to newborns in-
creased the total reflux time dramatically (P <
.001), and the number of episodes of reflux in half
of the patients studied. A correlation with plasma
levels of caffeine could not be demonstrated, al-
though levels were within therapeutic ranges (5 to
20 zg/ml)” in 80% of infants, and higher, toxic
‘ were not detected. In 20% of infants levels
did not reach therapeutic ranges.
The finding of normal results for esophageal pH
monitoring in all infants before and 3 to 4 weeks
after the administration of the xanthines was
stopped indicates that gastrointestinal reflux was
not present before therapy. Therefore, there is a
correlation with the administration of xanthines,
as this was the only parameter that had changed.
No reason could be detected for the difference of
response in the infants studied, except for the pres-
ence of individual (hyper) sensitivity toward the
drug, a well-known effect of xanthines.”
Gastroesophageal reflux is a well-known risk fac-
tor for SIDS.’2 Abnormal results of cardiorespira-
tory monitoring in infants with gastrointestinal
reflux can be normalized when gastrointestinal re-
flux is treated correctly.’2 Therefore, we discourage
the administration of caffeine in infants at risk for
SIDS, if screening for gastrointestinal reflux is not
performed routinely.
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